Veliparib Plus Temozolomide for MGMT-Methylated Glioblastoma-Reply

被引:0
|
作者
Sarkaria, Jann N. [1 ]
Kizilbash, Sani H. [1 ]
Giannini, Caterina [1 ]
机构
[1] Mayo Clin, Rochester, MN USA
关键词
D O I
10.1001/jamaoncol.2025.0032
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Veliparib Plus Temozolomide for MGMT-Methylated Glioblastoma
    Wilson, Liam
    Atallah, Aline
    JAMA ONCOLOGY, 2025,
  • [2] Efficacy of Adding Veliparib to Temozolomide for Patients With MGMT-Methylated Glioblastoma
    Sarkaria, Jann N.
    Ballman, Karla V.
    Kizilbash, Sani H.
    Sulman, Erik P.
    Giannini, Caterina
    Friday, Bret B.
    Butowski, Nicholas A.
    Mohile, Nimish A.
    Piccioni, David E.
    Battiste, James D.
    Drappatz, Jan
    Campian, Jian L.
    Mashru, Sandeep
    Jaeckle, Kurt A.
    O'Brien, Barbara J.
    Dixon, Jesse G.
    Kabat, Brian F.
    Laack, Nadia L.
    Hu, Leland S.
    Kaufmann, Timothy
    Kumthekar, Priya
    Ellingson, Benjamin M.
    Anderson, S. Keith
    Galanis, Evanthia
    JAMA ONCOLOGY, 2024, 10 (12) : 1637 - 1644
  • [3] Efficacy of Adding Veliparib to Temozolomide for Patients With MGMT-Methylated Glioblastoma: A Randomized Clinical Trial (vol 10, pg 1637, 2024)
    Sarkaria, J. N.
    Ballman, K., V
    Kizilbash, S. H.
    JAMA ONCOLOGY, 2024, 10 (12) : 1736 - 1736
  • [4] ELUCIDATING THE MECHANISM OF TEMOZOLOMIDE-INDUCED ATR ACTIVATION IN MGMT-METHYLATED GLIOBLASTOMA MULTIFORME
    Ganesa, Sachita
    Sule, Amrita
    Sundaram, Ranjini
    Bindra, Ranjit
    NEURO-ONCOLOGY, 2020, 22 : 18 - 18
  • [5] Dynamic structural remodeling of LINC01956 enhances temozolomide resistance in MGMT-methylated glioblastoma
    Liao, Xinyi
    Zhang, Shuxia
    Li, Xincheng
    Qian, Wanying
    Li, Man
    Chen, Suwen
    Wu, Xingui
    Yu, Xuexin
    Li, Ziwen
    Tang, Miaoling
    Xu, Yingru
    Yu, Ruyuan
    Zhang, Qiliang
    Wu, Geyan
    Zhang, Nu
    Song, Libing
    Li, Jun
    SCIENCE TRANSLATIONAL MEDICINE, 2024, 16 (767)
  • [6] Mismatch repair proteins play a role in ATR activation upon temozolomide treatment in MGMT-methylated glioblastoma
    Ganesa, Sachita
    Sule, Amrita
    Sundaram, Ranjini K.
    Bindra, Ranjit S.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [7] IDENTIFYING THE ROLE OF MISMATCH REPAIR IN TEMOZOLOMIDE-INDUCED ATR ACTIVATION FOR MGMT-METHYLATED GLIOBLASTOMA MULTIFORME
    Ganesa, Sachita
    Sule, Amrita
    Sundaram, Ranjini
    Bindra, Ranjit
    NEURO-ONCOLOGY, 2021, 23 : 32 - 32
  • [8] Mismatch repair proteins play a role in ATR activation upon temozolomide treatment in MGMT-methylated glioblastoma
    Sachita Ganesa
    Amrita Sule
    Ranjini K. Sundaram
    Ranjit S. Bindra
    Scientific Reports, 12
  • [9] Epigenetic Markers Identify MGMT-methylated Glioblastoma Poorly Responding to Combined Radiotherapy-temozolomide (Stupp Regimen)
    Aubry, M.
    Etcheverry, A.
    Idbaih, A.
    Marie, Y.
    Sanson, M.
    Delattre, J. Y.
    Mosser, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S95 - S95
  • [10] DIAPH3 predicts survival of patients with MGMT-methylated glioblastoma
    Chehade, Georges
    El Hajj, Nady
    Aittaleb, Mohamed
    Alkailani, Maisa I.
    Bejaoui, Yosra
    Mahdi, Asma
    Aldaalis, Arwa A. H.
    Verbiest, Michael
    Lelotte, Julie
    Ruiz-Reig, Nuria
    Dura, Irene
    Raftopoulos, Christian
    Tajeddine, Nicolas
    Tissir, Fadel
    FRONTIERS IN ONCOLOGY, 2024, 14